Immunoprotective Effect of Red Blood Cell Membrane-Coated Nanoparticles Against Clostridium Perfringens Epsilon Toxin
Clinical Laboratory · 2026 · 72 (11/2026)
DOI: 10.7754/clin.lab.2025.251010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Sima Pooyan und 4 weiteren Autor:innen.
Abstract (Originalsprache)
BACKGROUND: Clostridium perfringens epsilon toxin is a highly potent pore-forming toxin responsible for fatal enterotoxemia in livestock. Current vaccines require complex production steps and may induce suboptimal immune responses. This study aimed to develop RBC membrane coated PLGA nanoparticles loaded with ETX toxoid (RVNTs), evaluate their immunogenicity, specificity, and protective efficacy in rabbits, and compare them with bare nanoparticles (NTs) and a commercial vaccine. METHODS: Toxin-loaded poly (lactic-co-glycolic acid) nanoparticles and RBC membrane-coated NTs were synthesized and characterized by quantitative and qualitative assays. RVNTs were prepared by fusing purified rabbit RBC membranes with ETX-loaded PLGA nanoparticles and characterized for safety, residual toxicity, and potency. Thirty-five rabbits were immunized under single- or three-dose regimens with NTs, RVNTs, heat-treated NTs alongside commercial vaccine and PBS controls. Anti-ETX titers were quantified over 150 days using an optimized indirect ELISA and validated by mouse neutralization tests. Protective efficacy was assessed via subcutaneous challenge with 100 MLD of activated ETX. RESULTS: The iELISA showed high sensitivity, specificity, and reproducibility, with no cross-reactivity to other clostridial toxins. Three-dose regimens induced significantly higher and more sustained antibody titers than single-dose regimens (p < 0.05). RVNTs elicited stronger responses than NTs, with RVNTs-exp2 achieving the highest titers and complete survival post-challenge. Heat treatment did not impair NTs' immunogenicity. The commercial vaccine showed rapid antibody decline and failed to protect beyond 24 hours, whereas RVNT-treated groups maintained elevated titers and protection for 150 days. CONCLUSIONS: RBC membrane-coated PLGA nanotoxoids provide enhanced stability, prolonged circulation, and potent, long-lasting immunity against ETX, outperforming bare nanoparticles and conventional vaccines. RVNTs represent a promising next-generation nanovaccine platform for preventing clostridial enterotoxemia, though further multi-species and long-term studies are warranted.
Zitieren
APA
Pooyan, S., Kazemipour, N., Bafti, M., Alimolaei, M., & Rokhbakhsh-Zamin, F. (2026). Immunoprotective Effect of Red Blood Cell Membrane-Coated Nanoparticles Against Clostridium Perfringens Epsilon Toxin. Clinical Laboratory, 72(11/2026). https://doi.org/10.7754/clin.lab.2025.251010
Vancouver
Pooyan S, Kazemipour N, Bafti M, Alimolaei M, Rokhbakhsh-Zamin F. Immunoprotective Effect of Red Blood Cell Membrane-Coated Nanoparticles Against Clostridium Perfringens Epsilon Toxin. Clinical Laboratory. 2026;72(11/2026). doi:10.7754/clin.lab.2025.251010
BibTeX
@article{Pooyan2026,
author = {Pooyan, Sima and Kazemipour, Nadia and Bafti, Mehrdad and Alimolaei, Mojtaba and Rokhbakhsh-Zamin, Farokh},
title = {Immunoprotective Effect of Red Blood Cell Membrane-Coated Nanoparticles Against Clostridium Perfringens Epsilon Toxin},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {11/2026},
doi = {10.7754/clin.lab.2025.251010}
}
EUVIMED